Chris Diorio Rph.

Chris Diorio, RPh has a strong background in pharmaceutical research and development. Chris worked as the Director of Research and Development at PharmaCann LLC from November 2016 to present. Prior to that, they were the Senior Director of Product Development and Manufacturing at IM HealthScience from March 2015 to February 2017. Chris also held the position of Director of Pharmaceutical R&D at Capsugel from June 2010 to March 2015. Chris began their career at Pfizer in 1994 and held various roles including Director and Research Scientist, working on formulation development and clinical trials. Chris also worked as a Pharmaceutical Formulator and Biochemist at American Cyanamid from 1987 to 1994.

Chris Diorio, RPh, holds a variety of degrees in pharmacy and related fields. Chris began their education at the State University of New York College of Agriculture and Technology at Morrisville, where they obtained an Associate's degree. Chris then went on to earn a Bachelor of Science degree in Biology/microbiology from the State University of New York College of Environmental Science and Forestry. Chris furthered their education at Long Island University, where they acquired a Bachelor of Science in Pharmacy. Continuing their studies, they pursued a Master's degree in Industrial Pharmacy from the same institution.